Cargando…
Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus
Mammalian target of rapamycin inhibitors (mTORi) are used to treat a variety of malignancies and have an established role in organ transplantation. Interstitial lung disease (ILD) is one of the complications of mTORi and is believed to be a class effect. More cases of ILD have been reported with sir...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287142/ https://www.ncbi.nlm.nih.gov/pubmed/32551222 http://dx.doi.org/10.1016/j.rmcr.2020.101109 |
_version_ | 1783545006700625920 |
---|---|
author | Alkhunaizi, Ahmed M. Al-Khouzaie, Thamer H. Alsagheir, Ahmed I. |
author_facet | Alkhunaizi, Ahmed M. Al-Khouzaie, Thamer H. Alsagheir, Ahmed I. |
author_sort | Alkhunaizi, Ahmed M. |
collection | PubMed |
description | Mammalian target of rapamycin inhibitors (mTORi) are used to treat a variety of malignancies and have an established role in organ transplantation. Interstitial lung disease (ILD) is one of the complications of mTORi and is believed to be a class effect. More cases of ILD have been reported with sirolimus than with everolimus in the literature, possibly due to earlier introduction and wider use of sirolimus. We report the case of a kidney transplant recipient who developed ILD secondary to sirolimus and improved rapidly after switching to everolimus. |
format | Online Article Text |
id | pubmed-7287142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72871422020-06-17 Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus Alkhunaizi, Ahmed M. Al-Khouzaie, Thamer H. Alsagheir, Ahmed I. Respir Med Case Rep Case Report Mammalian target of rapamycin inhibitors (mTORi) are used to treat a variety of malignancies and have an established role in organ transplantation. Interstitial lung disease (ILD) is one of the complications of mTORi and is believed to be a class effect. More cases of ILD have been reported with sirolimus than with everolimus in the literature, possibly due to earlier introduction and wider use of sirolimus. We report the case of a kidney transplant recipient who developed ILD secondary to sirolimus and improved rapidly after switching to everolimus. Elsevier 2020-06-02 /pmc/articles/PMC7287142/ /pubmed/32551222 http://dx.doi.org/10.1016/j.rmcr.2020.101109 Text en © 2020 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Alkhunaizi, Ahmed M. Al-Khouzaie, Thamer H. Alsagheir, Ahmed I. Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
title | Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
title_full | Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
title_fullStr | Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
title_full_unstemmed | Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
title_short | Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
title_sort | sirolimus-induced interstitial lung disease and resolution after conversion to everolimus |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287142/ https://www.ncbi.nlm.nih.gov/pubmed/32551222 http://dx.doi.org/10.1016/j.rmcr.2020.101109 |
work_keys_str_mv | AT alkhunaiziahmedm sirolimusinducedinterstitiallungdiseaseandresolutionafterconversiontoeverolimus AT alkhouzaiethamerh sirolimusinducedinterstitiallungdiseaseandresolutionafterconversiontoeverolimus AT alsagheirahmedi sirolimusinducedinterstitiallungdiseaseandresolutionafterconversiontoeverolimus |